ClinicalTrials.Veeva

Menu

Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients

A

Ahmed Fathy Ali Mohamed Ghanem

Status

Completed

Conditions

Female Infertility Associated With Anovulation

Treatments

Drug: Clomifene citrate ( clomid 50 mg )
Drug: Amlodipine

Study type

Interventional

Funder types

Other

Identifiers

NCT02544776
effect of amlodipine in pco

Details and patient eligibility

About

On the basis of the current study, amlodipine seems to be a promising drug on improving uterine, ovarian blood flow, size of pre-ovulatory follicle, midluteal progesterone level and pregnancy outcome in patients with pco.

Full description

To know if amlodipine has vasodilator effect on ovarian ar. In pco patient.

Enrollment

60 patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Demographic features including females in age of ≥20 & ≤35, and BMI of ≤39.

  • Infertility secondary to polycystic ovary , The choice of polycystic ovary patients will be according to the Rotterdam consensus workshop (Rotterdam, 2004), and the diagnosis of polycystic ovary by ultrasonography will be made according to Adams et al. criteria which are the most often cited (Adams et al., 1985).The Rotterdam criteria as follows:

    • Oligo- or anovulation.
    • Clinical and/or biochemical signs of hyper androgynism
    • The presence of polycystic ovaries on ultrasound scan. Ultrasound findings of enlarged ovaries with multiple small cysts (10-12 or more of 2-9 mm in diameter) scattered around the periphery and highly echogenic stroma

Exclusion criteria

  • Including other causes of infertility diagnosed during infertility work up.
  • Patients refused to participate or to continue study.
  • Also, hepatic, cardiac, and hypotensive patients will be excluded from the study.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

60 participants in 2 patient groups

Clomifene citrate and Amlodipine
Experimental group
Description:
Amlodipine 5mg tablet and Clomifene citrate 50 mg tablet once by mouth daily at morning starting from day number 5 of menstrual cycle till day number 9.
Treatment:
Drug: Amlodipine
Drug: Clomifene citrate ( clomid 50 mg )
Clomifene citrate
Active Comparator group
Description:
Clomifene citrate 50mg and once daily at morning starting from day number 5 of menstrual cycle till day number 9
Treatment:
Drug: Clomifene citrate ( clomid 50 mg )

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems